Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Beryl Drugs Ltd.
Swot
Beryl Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Beryl Drugs Ltd. has 14 Strengths, 8 Weaknesses, 0 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(14)
Weakness
(8)
Opportunity
(0)
Threats
(1)
Others
(4)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
RSI indicating price strength
Stocks in uptrend most likely to cross above SMA-200 soon
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
PE higher than Industry PE
High PE (PE > 40)
Inefficient use of shareholder funds - ROE declining in the last 2 years
Degrowth in Revenue and Profit
Major fall in TTM Net Profit
Fall in Quarterly Revenue and Net Profit (YoY)
Biggest Price Losers from Open
Top Losers
Stocks rising sharply on very low month volumes
Bullish or Bearish Candlestick Strength - Indices
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
